3-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenylethynyl-trimethylsilane

Product Information

Molecular Formula:
C17H25BO2Si
Molecular Weight:
0
Description
3-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenylethynyl-trimethylsilane is an indispensable compound within the biomedical domain. It assumes a pivotal role in the fabrication of curative medications targeted towards an array of ailments. By virtue of its distinct constitution, it enables proficient amalgamation of pharmaceutical agents, specifically those devised for combating cancerous afflictions and neurodegenerative conditions. Possessing remarkable adaptability, this versatile compound exhibits auspicious prospects for propelling progress in biomedical investigations and therapeutic innovations.
Synonyms
4,4,5,5-Tetramethyl-2-[(3-trimethylsilylethynyl)phenyl]-[1,3,2]dioxaborolane
IUPAC Name
trimethyl-[2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethynyl]silane
Canonical SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CC(=CC=C2)C#C[Si](C)(C)C
InChI
InChI=1S/C17H25BO2Si/c1-16(2)17(3,4)20-18(19-16)15-10-8-9-14(13-15)11-12-21(5,6)7/h8-10,13H,1-7H3
InChI Key
LDKJXCOLGXLWKP-UHFFFAOYSA-N
Melting Point
86-90 °C
Flash Point
Not applicable
Purity
95%

Computed Properties

Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
2
Rotatable Bond Count
3
Exact Mass
300.1716867 g/mol
Monoisotopic Mass
300.1716867 g/mol
Topological Polar Surface Area
18.5Ų
Heavy Atom Count
21
Formal Charge
0
Complexity
436
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes

Patents

Publication Number Title Priority Date
KR-20200012876-A Paramycin Analogues as mTOR Inhibitors 2017-05-02
JP-2020518632-A Rapamycin analogues as mTOR inhibitors 2017-05-02
US-2021094975-A1 Rapamycin analogs as mtor inhibitors 2017-05-02
AU-2014274644-A1 New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them 2013-12-23
DK-2886545-T3 Thienopyrimidinderivater new, a process for their preparation and pharmaceutical compositions containing them 2013-12-23
EP-2886545-A1 New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them 2013-12-23
EP-2886545-B1 New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them 2013-12-23
HU-E029654-T2 New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them 2013-12-23
JP-2015129120-A Novel thienopyrimidine derivative, process for producing the same and pharmaceutical composition containing the same 2013-12-23
JP-5922215-B2 Novel thienopyrimidine derivative, process for producing the same and pharmaceutical composition containing the same 2013-12-23
The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Online Inquiry
  • Verification code
USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Copyright © 2024 BOC Sciences. All rights reserved.
Inquiry Basket